Abstract |
|
Authors | S Cascinu, L Verdecchia, N Valeri, R Berardi, M Scartozzi |
Journal | Annals of oncology : official journal of the European Society for Medical Oncology
(Ann Oncol)
Vol. 17 Suppl 5
Pg. v148-52
(May 2006)
ISSN: 1569-8041 [Electronic] England |
PMID | 16807445
(Publication Type: Evaluation Study, Journal Article, Review)
|
Chemical References |
- Cyclooxygenase 2 Inhibitors
- NF-kappa B
- Protease Inhibitors
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Farnesyltranstransferase
- EGFR protein, human
- ErbB Receptors
- Metalloproteases
|
Topics |
- Cyclooxygenase 2 Inhibitors
(therapeutic use)
- Disease Progression
- Drug Delivery Systems
- ErbB Receptors
(antagonists & inhibitors)
- Farnesyltranstransferase
(antagonists & inhibitors)
- Gene Targeting
- Humans
- Metalloproteases
(antagonists & inhibitors)
- NF-kappa B
(antagonists & inhibitors)
- Pancreatic Neoplasms
(enzymology, genetics, pathology, therapy)
- Protease Inhibitors
(therapeutic use)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
|